Tilray sends pot stocks lower after Q4 results
Source: SeekingAlpha
2025-07-29 11:19:30 ET
More on Tilray
- Tilray Brands, Inc. (TLRY) Q4 2025 Earnings Call Transcript
- Tilray Q4 Results Show Major Problems
- Why I Am Downgrading Tilray Brands
- Tilray outlines $62M-$72M adjusted EBITDA guidance for 2026 amid international cannabis surge and beverage business reset
- Tilray Brands Q4 Earnings Preview: What to expect
Read the full article on Seeking Alpha
For further details see:
Tilray sends pot stocks lower after Q4 results
MariMed Inc
NASDAQ: MRMD
MRMD Trading
2.43% G/L:
$0.0802 Last:
109,452 Volume:
$0.07666 Open:
MRMD Latest News
March 02, 2026 04:15:00 pm
MariMed Extends Series B Preferred Stock Obligation Through 2031, Strengthening Capital Structure
